Your browser doesn't support javascript.
Correction to "Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir".
Chen, Ting; Fei, Cheng-Yin; Chen, Yi-Ping; Sargsyan, Karen; Liang, Jian-Jong; Liao, Chun-Che; Lin, Yi-Ling; Chang, Chun-Ping; Yuan, Hanna S; Lim, Carmay.
  • Chen T; Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
  • Fei CY; Institute of Molecular Biology, Academia Sinica, Taipei 115, Taiwan.
  • Chen YP; Institute of Molecular Biology, Academia Sinica, Taipei 115, Taiwan.
  • Sargsyan K; Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
  • Liang JJ; Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
  • Liao CC; Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
  • Lin YL; Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
  • Chang CP; Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 350, Taiwan.
  • Yuan HS; Institute of Molecular Biology, Academia Sinica, Taipei 115, Taiwan.
  • Lim C; Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
ACS Pharmacol Transl Sci ; 4(3): 1246, 2021 Jun 11.
Article in English | MEDLINE | ID: covidwho-1387159
ABSTRACT
[This corrects the article DOI 10.1021/acsptsci.1c00022.].

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: ACS Pharmacol Transl Sci Year: 2021 Document Type: Article Affiliation country: ACSPTSCI.1C00106

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: ACS Pharmacol Transl Sci Year: 2021 Document Type: Article Affiliation country: ACSPTSCI.1C00106